Skip to content

Novel Multifocal Soft Contact Lens Study

Novel Multifocal Soft Contact Lens Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06172881
Enrollment
10
Registered
2023-12-15
Start date
2023-12-14
Completion date
2024-01-12
Last updated
2024-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

A single site, open label protocol will be used to evaluate the safety and quality of vision of a novel soft contact lens. Habitual contact lens wearers will be asked to come to the study site for one visit. Ocular health assessments and visual acuity will be completed with both the study lens and without.

Interventions

A soft contact lens that will be worn only at the study visit.

Sponsors

Myoptechs
CollaboratorINDUSTRY
Ohio State University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Ability to give informed consent 2. Any gender 3. Any racial or ethnic origin 4. 18 - 40 years of age 5. Distance visual acuity with best corrected visual acuity of 20/25 with each eye 6. Habitual soft contact lens wearer with myopia 7. Good general health (defined by medication use that has not changed within the last month and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the investigator).

Exclusion criteria

1. Current or active ocular inflammation or infection as determined by the Investigator. 2. Astigmatism \> 0.75 D in either eye 3. History of previous eye surgery 4. Demonstration or history of corneal ectasia or keratoconus. 5. Pregnant or lactating.

Design outcomes

Primary

MeasureTime frameDescription
Distance Visual Acuity1 day (This is a single visit study)LogMAR typically ranges from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). Lower scores indicate better vision.

Countries

United States

Participant flow

Participants by arm

ArmCount
Distance Visual Acuity
Visual acuity will be measured while participant's wear study lenses. Investigational Contact Lens: A soft contact lens that will be worn only at the study visit.
10
Total10

Baseline characteristics

CharacteristicDistance Visual Acuity
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
Age, Continuous
Age
29.3 years
STANDARD_DEVIATION 5.9
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
2 Participants
Race (NIH/OMB)
Black or African American
2 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
6 Participants
Region of Enrollment
United States
10 participants
Sex: Female, Male
Female
8 Participants
Sex: Female, Male
Male
2 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 10
other
Total, other adverse events
0 / 10
serious
Total, serious adverse events
0 / 10

Outcome results

Primary

Distance Visual Acuity

LogMAR typically ranges from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). Lower scores indicate better vision.

Time frame: 1 day (This is a single visit study)

ArmMeasureGroupValue (MEAN)Dispersion
Distance Visual AcuityDistance Visual AcuityHigh Contrast Distance Visual Acuity OD-0.13 logMARStandard Deviation 0.08
Distance Visual AcuityDistance Visual AcuityHigh Contrast Distance Visual Acuity OS-0.12 logMARStandard Deviation 0.09

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026